U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Undiagnosed diabetes costs U.S. $18 billion a year

Printer-friendly version E-mail this page to a friend

Reuters Health

Wednesday, May 6, 2009

CHICAGO (Reuters) - About 6.3 million Americans have diabetes without knowing it, and complications from their undiagnosed disease account for an estimated $18 billion in U.S. healthcare costs each year, U.S. researchers said on Wednesday.

Prior studies have shown that diabetes cost the U.S. economy about $174 billion in 2007 in medical expenses and lost productivity.

But many people often begin having complications from diabetes years before they get a diagnosis, and these costs are often overlooked, according to the study by Yiduo Zhang of the healthcare research company the Lewin Group and published in the journal Population Health Management.

Zhang and colleagues studied the healthcare use patterns of nearly 30,000 people for the 2-year period leading up to a diagnosis of diabetes and compared them with medical claims of people never diagnosed with diabetes.

They estimated that undiagnosed diabetes in 2007 cost an additional $2,864 per person, or a total of $18 billion per year.

Complications often present in people with newly diagnosed diabetes include retina damage, nerve pain and heart disease. They said programs aimed at earlier detection and treatment could help reduce these costs.

(Reporting by Julie Steenhuysen; Editing by Xavier Briand)


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: